Felimazole Patent Expiration

Felimazole Petitions

Details of Felimazole's suitability petitions are listed below.

Petitioner Action Date of Action Description
Petitions Data
e5 Pharma, LLC. Approved 13 Jan, 2015 The generic product will differ in dosage form. The RLNAD is approved as a film-coated tablet. The proposed dosage form is an oral solution.
e5 Pharma, LLC. Approved 26 Aug, 2014 The generic product will differ in dosage form. The RLNAD is approved as a film-coated tablet. The proposed dosage form is a soft chewable tablet.

About Felimazole

Felimazole is a drug owned by DECHRA VETERINARY PRODUCTS LLC . Felimazole uses Methimazole as the active ingredient.

Active Ingredient:

Felimazole uses Methimazole as the active ingredient. Check out other Drugs and Companies using Methimazole ingredient.